|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/713 | |||
| A61P 27/02 |
| (11) | Number of the document | 2862929 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14195359.6 |
| Date of filing the European patent application | 2010-12-09 | |
| (97) | Date of publication of the European application | 2015-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 267835 P | 2009-12-09 | US | |
| 319894 P | 2010-04-01 | US |
| (72) |
Feinstein, Elena, IL
Spivak, Igor, IL
Alpert, Evgenia, IL
Lahav, Ron, IL
|
| (73) |
Quark Pharmaceuticals, Inc.,
6501 Dumbarton Circle, Fremont, California 94555,
US
|
| (54) | Compositions and methods for treating diseases, disorders or injury of the CNS |
| Compositions and methods for treating diseases, disorders or injury of the CNS |